Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects
about
A polymorphism in the beta1 adrenergic receptor is associated with resting heart rateIdentification of the endophilins (SH3p4/p8/p13) as novel binding partners for the beta1-adrenergic receptorG-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingSimilarly potent inhibition of adenylyl cyclase by P-site inhibitors in hearts from wild type and AC5 knockout miceAltered pharmacological effects of adrenergic agonists during hypothermiaRemoval of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signalingalpha(1)-Adrenoceptor subtypes in the mouse mesenteric artery and abdominal aortaDecreased blood pressure response in mice deficient of the alpha1b-adrenergic receptorSignaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4Homeostasis as the Mechanism of EvolutionDifferential contribution of beta-adrenergic receptors expressed on radiosensitive versus radioresistant cells to protection against inflammation and mortality in murine endotoxemiaRedundant catecholamine signaling consolidates fear memory via phospholipase C.Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.Early expression of a beta1-adrenergic receptor and catecholamines in Xenopus oocytes and embryos.Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the Rb-related p107 gene.Use of electron microscopy in the detection of adrenergic receptorsBeta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouseThe slow afterhyperpolarization: a target of β1-adrenergic signaling in hippocampus-dependent memory retrieval.Total beta-adrenoceptor knockout slows conduction and reduces inducible arrhythmias in the mouse heart.Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.Maternal diet-induced obesity programs cardiovascular dysfunction in adult male mouse offspring independent of current body weightEvidence for a critical role of catecholamines for cardiomyocyte lineage commitment in murine embryonic stem cells.Differential regulation of two palmitoylation sites in the cytoplasmic tail of the beta1-adrenergic receptorDesensitization and resensitization of beta 1- and putative beta 4-adrenoceptor mediated responses occur in parallel in a rat model of cardiac failureQuantification of beta adrenergic receptor subtypes in beta-arrestin knockout mouse airways.THE ROLE OF β-ADRENERGIC RECEPTORS IN HEART FAILURE: DIFFERENTIAL REGULATION OF CARDIOTOXICITY AND CARDIOPROTECTION.Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Giα-coupled β2-adrenoceptor signaling pathwayExercise assessment of transgenic models of human cardiovascular disease.Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes.Stress and glucocorticoids impair memory retrieval via β2-adrenergic, Gi/o-coupled suppression of cAMP signalingAnti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlationThe β2-adrenergic receptor as a surrogate odorant receptor in mouse olfactory sensory neuronsMRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytesTrans-Golgi Network (TGN) as a regulatory node for β1-adrenergic receptor (β1AR) down-modulation and recycling.The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes.Cardiac β2-Adrenergic Receptor Phosphorylation at Ser355/356 Regulates Receptor Internalization and Functional Resensitization.Physiological and genomic consequences of adrenergic deficiency during embryonic/fetal development in mice: impact on retinoic acid metabolism.Compartmentalization of beta-adrenergic signals in cardiomyocytes.Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.Hypertension, kidney, and transgenics: a fresh perspective.
P2860
Q24613583-716CD88E-DC38-4210-9800-F1A66132F542Q24653887-6C7356C7-2343-4F9E-9428-1150A0B85C2BQ26772221-E07138EC-33B8-4695-BB5B-6D1E60A59087Q27311590-ABF9BE36-2471-4D2D-A416-080E1E17DA93Q28078697-E4B8093A-24DF-4D56-8DBA-9F5CD240B665Q28295123-B9B386FC-1C9A-4F6C-892C-18DB1B201CB3Q28362738-8107B76B-085B-4B3B-B7CC-AD579300C7FDQ28504510-B8338746-CE0D-4539-9186-D0FE31AAD66AQ28590119-6ACE09F4-E8AF-4959-9887-8FC36DBA7118Q28607085-945F4805-788E-4B10-8FE2-D36FB749AFD0Q30434377-C53648C3-554F-4C37-A3AF-1693BB4203DFQ30464844-60366F4F-7DC2-471C-8A11-0883DEE297EAQ30548452-08D5D6C4-1F27-4F71-9654-6C6C1E7FD4EFQ32184878-39B8180C-6B99-4979-85CB-4961F25D3970Q33781802-AD2594B3-E6A5-47A5-82DB-8318FAE09A2AQ33844076-C2FBA689-9849-4830-B472-537B2137B48FQ33858191-30DE59DB-0443-48FF-BBAB-3C5624AE29FAQ34332796-B81DAAA5-37AA-4533-BF21-CD33E86034ECQ34469952-0B5E7C35-CE91-4C84-9686-65BFE820556CQ34498911-9EE459F4-14B9-4558-95C9-6D4D2F924690Q34628879-305714A6-A57F-4E9C-9139-7A136322FCF3Q34926288-2AB5C12B-54B1-4E78-94E8-95D920A8778DQ34998252-3D89CABA-9BCC-48BE-93F1-4FE452A0CD27Q35041727-B4E1B376-09A1-4F1D-96CC-A791D25F8E29Q35057786-48D4351F-7414-43A2-8EFC-3EF6EB85951BQ35104064-44872F3D-27F0-486B-9960-B1294C1CA484Q35119132-61BB971A-D0D9-4D87-AE46-C3498B6585E1Q35127294-4657D0F0-F535-4EE8-844D-6419DFB77954Q35395744-2D5BD762-5104-4250-B3BE-D4021C750DE8Q35436140-A90E7E8A-5E6B-4537-AF4C-68B00F218B51Q35774994-B0CB1333-A37F-4052-AEC5-3ECB4D728DA6Q35820854-BFCA6A43-17E4-4184-A2B4-AEF4CD6CE5DAQ35840336-F02C1AB5-85A3-47F4-8585-2FF337A7A623Q35922381-8FF4E365-6774-45F5-8B41-6DF329CA424EQ35978071-3514D4E1-FAC7-4812-AF01-6E94848F08B2Q36107878-97F31EBC-AFD4-449A-83E4-C188DE82D411Q36320707-0E03E19B-E716-4FD3-8606-17334CEEC62DQ36384788-E4BD4F54-8AE8-48AF-8392-214FA8B66EDDQ36391033-CEFB7A98-05B7-487E-BB2C-570094F3F9EAQ36443015-F426B8FC-0D99-4431-A68E-C9A6A1FA7540
P2860
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects
description
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1996
@ast
im Juli 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/07/09)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/07/09)
@nl
наукова стаття, опублікована в липні 1996
@uk
name
Targeted disruption of the mou ...... tal and cardiovascular effects
@ast
Targeted disruption of the mou ...... tal and cardiovascular effects
@en
Targeted disruption of the mou ...... tal and cardiovascular effects
@nl
type
label
Targeted disruption of the mou ...... tal and cardiovascular effects
@ast
Targeted disruption of the mou ...... tal and cardiovascular effects
@en
Targeted disruption of the mou ...... tal and cardiovascular effects
@nl
prefLabel
Targeted disruption of the mou ...... tal and cardiovascular effects
@ast
Targeted disruption of the mou ...... tal and cardiovascular effects
@en
Targeted disruption of the mou ...... tal and cardiovascular effects
@nl
P2093
P2860
P921
P3181
P356
P1476
Targeted disruption of the mou ...... tal and cardiovascular effects
@en
P2093
D. Bernstein
D. K. Rohrer
D. P. Regula
G. S. Barsh
J. R. Jasper
K. H. Desai
M. E. Stevens
P2860
P304
P3181
P356
10.1073/PNAS.93.14.7375
P407
P577
1996-07-09T00:00:00Z